Fundraising Fox
Azkarra Therapeutics
South San Francisco, US · Founded 2007 · 26 employees on LinkedIn · 1 known investors
Find your way into Azkarra Therapeutics
Sign up to see every warm intro you have to Azkarra Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Azkarra Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Azkarra Therapeutics develops small molecule drugs targeting DNA damage repair and immune response pathways for cancer and inflammatory diseases. The company focuses on novel PARP inhibitors, PARG inhibitors, and OGG1 inhibitors as next-generation precision therapeutics.
Founders & leadership
Azkarra Therapeutics was founded in 2007 by Alan Ashworth and Alan Ashworth, Ph.D., FRS.
AA
Alan AshworthFounder
AA
Alan Ashworth, Ph.D., FRSScientific Founder
Investors · 1
Frequently asked questions
- What does Azkarra Therapeutics do?
- Azkarra Therapeutics develops small molecule drugs targeting DNA damage repair and immune response pathways for cancer and inflammatory diseases. The company focuses on novel PARP inhibitors, PARG inhibitors, and OGG1 inhibitors as next-generation precision therapeutics.
- Who founded Azkarra Therapeutics?
- Azkarra Therapeutics was founded by Alan Ashworth, Alan Ashworth, Ph.D., FRS in 2007.
- Who are Azkarra Therapeutics's investors?
- Azkarra Therapeutics's investors include Pandect Bioventures.
- Where is Azkarra Therapeutics headquartered?
- Azkarra Therapeutics is headquartered in South San Francisco, US.